Ignite Creation Date:
2025-12-25 @ 2:07 AM
Ignite Modification Date:
2026-06-14 @ 7:39 PM
Study NCT ID:
NCT04181060
Status:
RECRUITING
Last Update Posted:
2025-12-24
First Post:
2019-11-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Sponsor:
Organization: